| Chapter title |
Visualization and Quantification of Topoisomerase–DNA Covalent Complexes Using the Trapped in Agarose Immunostaining (TARDIS) Assay
|
|---|---|
| Chapter number | 21 |
| Book title |
DNA Topoisomerases
|
| Published in |
Methods in molecular biology, January 2018
|
| DOI | 10.1007/978-1-4939-7459-7_21 |
| Pubmed ID | |
| Book ISBNs |
978-1-4939-7458-0, 978-1-4939-7459-7
|
| Authors |
Ian G. Cowell, Caroline A. Austin |
| Abstract |
The TARDIS assay was originally developed as a means of detecting and quantifying melphalan and cisplatin DNA adducts at the single cell level, but it has since been adapted to quantify topoisomerase DNA complexes that result from the actions of topoisomerase poisons and this is currently the main use of the assay. The method employs sensitive immunofluorescent detection to quantify topoisomerase molecules covalently coupled to DNA in what are often referred to as cleavage complexes. Free topoisomerase molecules, and other cellular constituents are first removed using salt-detergent extraction of agarose-embedded, unfixed cells. Using these stringent extraction conditions, genomic DNA remains in place in the agarose as "nuclear ghosts," and any covalent attached molecules can be detected and quantified by immunofluorescence with a low background. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 9 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 44% |
| Professor > Associate Professor | 1 | 11% |
| Student > Doctoral Student | 1 | 11% |
| Researcher | 1 | 11% |
| Student > Master | 1 | 11% |
| Other | 0 | 0% |
| Unknown | 1 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 5 | 56% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 11% |
| Medicine and Dentistry | 1 | 11% |
| Unknown | 2 | 22% |